A panel of the Food and Drug Administration recommended that the agency authorize Pfizer-BioNTech’s coronavirus vaccine for emergency use.The decision was non binding, but it is likely to lead to FDA approval of the vaccine, perhaps in the next few days.
The FDA’s Vaccines and Related Biological Products Advisory Committee had a day-long discussion of the safety of the vaccine and any potential side effects, with medical experts weighing in on trial data.
The vote was 17 in favor and four against, with one abstention.The Trump administration has outlined plans to ship 2.9 million doses of the vaccine within 24 hours of approval.
Read more on deadline.com